ArticleJournal of sleep research2026
Associations Between Sleep Quality and Continuous Glucose Monitoring-Derived Metrics in Individuals With Type 2 Diabetes.
Article in Journal of sleep research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Sleep is a critical component of cardiometabolic health, yet individuals with Type 2 diabetes (T2D) experience disproportionately poor sleep quality. While extensive research links sleep duration and quality with HbA1c, less is known about the relationship between sleep and continuous glucose monitoring (CGM)-derived metrics, which capture short-term glycemic variability (GV) and time in range (TIR). Growing evidence suggests that CGM-derived metrics, particularly GV and TIR, are strongly associated with diabetes-related complications and all-cause mortality, underscoring their clinical importance. We conducted a study to examine associations between self-reported sleep quality and CGM-derived metrics among 137 adults with T2D. Participants completed the Pittsburgh Sleep Quality Index (PSQI) and wore blinded CGM devices for 14 days. CGM-derived metrics included intraday- and interday-GV (coefficient of variation, J-index, high/low blood glucose indices, mean of daily differences [MODD]), TIR, time above range (TAR) and time below range (TBR). Multivariable linear regression adjusted for age, sex, body mass index, diabetes duration, depressive symptoms and race/ethnicity. Overall, 69% of participants reported poor sleep. Poor sleep quality was independently associated with higher TAR (daytime β = 0.18, p = 0.04; nighttime β = 0.13, p = 0.04), lower TIR (daytime β = -0.09, p = 0.04; nighttime β = -0.05, p = 0.04) and greater day-to-day GV (β = 0.22, p = 0.03) and higher hyperglycemia risk (β = 0.23, p = 0.04). These findings suggest that poor sleep quality in T2D is linked to increased hyperglycemia exposure, reduced TIR and unstable day-to-day GV, independent of clinical factors. Addressing sleep as a modifiable lifestyle factor and integrating sleep assessments with CGM may provide actionable insights to guide personalised diabetes management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.